首頁 > 市場調查報告書 > 製藥

市場調查報告書

商品編碼

1562405

到 2030 年北美腸外營養市場預測 - 區域分析 - 按營養類型和最終用戶

North America Parenteral Nutrition Market Forecast to 2030 - Regional Analysis - by Nutrient Type and End User

出版日期: 2024年07月04日 | 出版商:

The Insight Partners | 英文 82 Pages | 訂單完成後即時交付

價格

簡介目錄圖表

2022年北美腸外營養市場估值為30.1206億美元，預計2030年將達48.0531億美元；預計2022年至2030年複合年成長率為6.0%。

胃腸道疾病盛行率上升推動北美腸外營養市場

克隆氏症、腸阻塞、潰瘍性結腸炎、短腸症候群、顯微鏡下結腸炎和胃癌是胃腸道疾病的一些例子。根據 2021 年 1 月發布的“羅馬基金會全球研究結果，功能性胃腸道疾病的全球盛行率和負擔”，功能性胃腸道疾病影響了全球超過 40% 的人。

根據2019年全球疾病負擔研究，2019年全球記錄了約490萬例發炎性腸道疾病（IBD）病例。潰瘍性結腸炎和克隆氏症是兩種常見的 IBD。克隆氏症是一種複雜的慢性疾病，主要影響消化系統。它是北美和歐洲最常見的疾病。根據 2020 年發表的題為「了解短腸症候群：現況與未來展望」的文章，過去 40 年來，短腸症候群 (SBS) 的盛行率增加了兩倍多。在美國，盛行率約為每百萬人 30 例，在歐洲約為每百萬人 1.4 例。

患有胃腸道疾病的患者營養惡化的風險較高，因為他們被要求在接受診斷測試之前禁食。他們也可能因治療性飲食限制而面臨營養惡化，以及厭食症或營養需求改變引起的食慾不振，這可能是疾病本身造成的。因此，對於無法攝取食物的胃腸道疾病患者，建議進行醫學營養治療。此外，優選腸胃外途徑來為它們提供必需的營養素。有些人可能不適合插管，這使得滿足他們的卡路里和營養需求變得困難。在這種情況下，優選腸外營養，以確保他們的身體保持水分並滿足維持身體健康和功能所需的熱量和其他營養攝取量。當患者因被診斷出患有影響胃腸道的癌症和慢性疾病等疾病而無法滿足營養需求時，就需要腸外營養。對於大多數患有嚴重 SBS 的患者來說，這種類型的營養是高度首選的治療選擇。因此，胃腸道疾病的日益普及推動了腸外營養市場的發展。

北美腸外營養市場概況

癌症、心臟病和其他慢性疾病是美國殘疾和死亡的主要原因。根據國家慢性病預防和健康促進中心的數據，該國每 10 人中有 6 人被診斷出患有至少一種慢性病。此外，美國醫院協會估計約有 1.33 億人患有至少一種慢性病，預計到 2030 年這一數字將達到 1.7 億人根據 2019 年 1 月發表的題為「腸外營養趨勢」的文章；在美國，平均每年約有 34,000 名患者接受腸外營養 (PN)。腸內管飼可用於治療 350 多種兒童疾病。

美國政府正努力透過各種措施讓人們了解腸內和腸外營養。例如，飼管意識基金會提高了人們對採用飼管作為救生醫療干預措施的認知，並幫助管飼兒童的父母。該基金會於 2019 年 2 月 4 日至 2 月 8 日慶祝了一年一度的飼管意識週。期內的市場成長。例如，2022 年 3 月，Fresenius Kabi 的 SMOFlipid 脂質注射乳液獲得 FDA 批准。該乳劑是第一個也是唯一一個適合所有年齡層需要腸外營養的患者的四油脂肪乳劑。

因此，需要醫療營養的慢性疾病發病率不斷上升、政府努力提高人們對腸外營養重要性的認知以及主要參與者的戰略舉措支持了美國腸外營養市場的成長。

北美腸外營養市場收入及 2030 年預測（百萬美元）

北美腸外營養市場細分

北美腸外營養市場根據營養素類型、最終用戶和國家進行細分。根據營養類型，北美腸外營養市場分為單劑量胺基酸溶液、腸外脂肪乳、碳水化合物、微量元素以及維生素和礦物質。 2022 年，單劑量胺基酸溶液細分市場佔據最大市場佔有率。

依最終用戶分類，北美腸外營養市場分為醫院、診所等。 2022 年，醫院細分市場佔據最大市場佔有率。

依國家分類，北美腸外營養市場分為美國、加拿大和墨西哥。 2022年，美國在北美腸外營養市場佔有率中佔據主導地位。

ICU Medical Inc、Grifols SA、輝瑞公司、大塚製藥有限公司、百特國際公司、B Braun SE、Fresenius Kabi AG、Aculife Healthcare Pvt Ltd 和 Vifor Pharma Management AG 是北美腸外營養領域的一些領先參與者市場。

Crohn's disease, bowel obstruction, ulcerative colitis, short bowel syndrome, microscopic colitis, and gastric cancer are a few examples of gastrointestinal diseases. According to the "Worldwide Prevalence and Burden of Functional Gastrointestinal Disorders, Results of Rome Foundation Global Study," published in January 2021, functional gastrointestinal disorders have affected over 40% of people across the globe.

Based on the Global Burden of Disease Study 2019, ~4.9 million cases of inflammatory bowel disease (IBD) were recorded worldwide in 2019. The US (762,890) registered the highest number of cases, with prevalence of 245.3 cases per 100,000 people, respectively. Ulcerative colitis and Crohn's disease are two of the commonly diagnosed IBDs. Crohn's disease is a complex, chronic disorder primarily affecting the digestive system. It is the most common disease in North America and Europe. As per the article titled "Understanding Short Bowel Syndrome: Current Status and Future Perspectives," published in 2020, the prevalence of short bowel syndrome (SBS) has increased by more than twofold in the last 40 years. The prevalence was ~30 cases per million in the US and approximately 1.4 cases per million in Europe.

Patients with gastrointestinal diseases are at an elevated risk of nutritional deterioration as they are asked to fast before undergoing diagnostic tests. They might also face nutritional deterioration due to therapeutic dietary restriction and loss of appetite caused by anorexia or altered nutritional requirements, which can be a result of the disease itself. Hence, medical nutrition is recommended for gastrointestinal disease patients as they are unable to ingest food. Further, the parenteral routes are preferred to provide them with essential nutrients. Some people might not show compatibility with tube insertion, which makes meeting their calorie and nutrient needs difficult. In such cases, parenteral nutrition is preferred to ensure their bodies remain hydrated and meet the calorie and other nutrient intake required to maintain physical well-being and function. Parenteral nutrition is indicated when patients cannot meet their nutritional needs as they are diagnosed with diseases such as cancer and chronic diseases, which affect the gastrointestinal tract. This type of nutrition is highly preferred as a therapy option for most patients suffering from severe SBS. Therefore, the growing prevalence of gastrointestinal diseases drives the parenteral nutrition market.

North America Parenteral Nutrition Market Overview

Cancer, heart disease, and other chronic diseases are the major causes of disability and death in the US. Per the National Center for Chronic Disease Prevention and Health Promotion, 6 in 10 people in the country are diagnosed with at least one chronic disease. Additionally, the American Hospital Association estimates that ~133 million people have at least one chronic disease, and that number is expected to reach 170 million by 2030. According to an article titled "Trends in Parenteral Nutrition," published in January 2019; on average, ~34,000 patients receive parenteral nutrition (PN) annually in the US. Enteral tube feeding can be prescribed for treating more than 350 disease conditions in children.

The US government is working on making people aware of enteral and parenteral nutrition through initiatives. For instance, the Feeding Tube Awareness Foundation creates awareness about the adoption of feeding tubes as a lifesaving medical intervention and helps parents of tube-fed children. The foundation celebrated the annual Feeding Tube Awareness Week from February 4, 2019, to February 8, 2019. In addition, a significant rise in US Food and Drug Administration (FDA) approvals of products by market players is likely to play a key role in the market growth during the forecast period. For instance, in March 2022, Fresenius Kabi received FDA approval for its SMOFlipid lipid injectable emulsion. The emulsion is the first and only four-oil lipid emulsion for patients of all ages requiring parenteral nutrition.

Therefore, the growing incidence of chronic diseases requiring medical nutrition, government efforts to raise awareness about the importance of parenteral nutrition, and strategic initiatives by key players support the growth of the parenteral nutrition market in the United States.

North America Parenteral Nutrition Market Revenue and Forecast to 2030 (US$ Million)

North America Parenteral Nutrition Market Segmentation

The North America parenteral nutrition market is segmented based on nutrient type, end user, and country. Based on nutrient type, the North America parenteral nutrition market is categorized into single dose amino acid solution, parenteral lipid emulsion, carbohydrates, trace elements, and vitamins & minerals. The single dose amino acid solution segment held the largest market share in 2022.

By end user, the North America parenteral nutrition market is segmented into hospitals, clinics, and others. The hospitals segment held the largest market share in 2022.

Based on country, the North America parenteral nutrition market is segmented into the US, Canada, and Mexico. The US dominated the North America parenteral nutrition market share in 2022.

ICU Medical Inc, Grifols SA, Pfizer Inc, Otsuka Pharmaceuticals Co Ltd, Baxter International Inc, B Braun SE, Fresenius Kabi AG, Aculife Healthcare Pvt Ltd, and Vifor Pharma Management AG are some of the leading players operating in the North America parenteral nutrition market.

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. North America Parenteral Nutrition Market - Key Industry Dynamics

4.1 Market Drivers
- 4.1.1 Rise in Prevalence of Gastrointestinal Diseases
- 4.1.2 Surge in Cases of Malnutrition and Premature Births
4.2 Market Restraints
- 4.2.1 Mechanical, Gastrointestinal, and Metabolic Complications Associated with Parenteral Feeding Systems
4.3 Market Opportunities
- 4.3.1 New Product Developments by Companies
4.4 Future Trends
- 4.4.1 Innovation in Formulations of Nutrition Products
4.5 Impact Analysis

5. Parenteral Nutrition Market - North America Market Analysis

5.1 Overview
5.2 Parenteral Nutrition Market Revenue (US$ Mn), 2020 - 2030

6. North America Parenteral Nutrition Market Analysis - by Nutrient Type

6.1 Overview
6.2 Single Dose Amino Acid Solution
- 6.2.1 Overview
- 6.2.2 Single Dose Amino Acid Solution: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
6.3 Parenteral Lipid Emulsion
- 6.3.1 Overview
- 6.3.2 Parenteral Lipid Emulsion: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
6.4 Carbohydrates
- 6.4.1 Overview
- 6.4.2 Carbohydrates: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
6.5 Trace Elements
- 6.5.1 Overview
- 6.5.2 Trace Elements: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
6.6 Vitamins and Minerals
- 6.6.1 Overview
- 6.6.2 Vitamins and Minerals: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)

7. North America Parenteral Nutrition Market Analysis - by End User

7.1 Overview
7.2 Hospitals
- 7.2.1 Overview
- 7.2.2 Hospitals: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
7.3 Clinics
- 7.3.1 Overview
- 7.3.2 Clinics: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Others
- 7.4.1 Overview
- 7.4.2 Others: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)

8. North America Parenteral Nutrition Market - Country Analysis

8.1 North America: Parenteral Nutrition Market
- 8.1.1 North America: Parenteral Nutrition Market - Revenue and Forecast Analysis - by Country
  - 8.1.1.1 United States: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
    - 8.1.1.1.1 Overview
    - 8.1.1.1.2 United States: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
    - 8.1.1.1.3 United States: Parenteral Nutrition Market Breakdown, by Nutrient Type
    - 8.1.1.1.4 United States: Parenteral Nutrition Market Breakdown, by End User
  - 8.1.1.2 Canada: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
    - 8.1.1.2.1 Overview
    - 8.1.1.2.2 Canada: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
    - 8.1.1.2.3 Canada: Parenteral Nutrition Market Breakdown, by Nutrient Type
    - 8.1.1.2.4 Canada: Parenteral Nutrition Market Breakdown, by End User
  - 8.1.1.3 Mexico: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
    - 8.1.1.3.1 Overview
    - 8.1.1.3.2 Mexico: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
    - 8.1.1.3.3 Mexico: Parenteral Nutrition Market Breakdown, by Nutrient Type
    - 8.1.1.3.4 Mexico: Parenteral Nutrition Market Breakdown, by End User

9. Industry Landscape

9.1 Overview
- 9.1.1 Overview

10. Company Profiles

10.1 ICU Medical Inc
- 10.1.1 Key Facts
- 10.1.2 Business Description
- 10.1.3 Products and Services
- 10.1.4 Financial Overview
- 10.1.5 SWOT Analysis
- 10.1.6 Key Developments
10.2 Grifols SA
- 10.2.1 Key Facts
- 10.2.2 Business Description
- 10.2.3 Products and Services
- 10.2.4 Financial Overview
- 10.2.5 SWOT Analysis
- 10.2.6 Key Developments
10.3 Pfizer Inc
- 10.3.1 Key Facts
- 10.3.2 Business Description
- 10.3.3 Products and Services
- 10.3.4 Financial Overview
- 10.3.5 SWOT Analysis
- 10.3.6 Key Developments
10.4 Otsuka Pharmaceuticals Co Ltd
- 10.4.1 Key Facts
- 10.4.2 Business Description
- 10.4.3 Products and Services
- 10.4.4 Financial Overview
- 10.4.5 SWOT Analysis
- 10.4.6 Key Developments
10.5 Baxter International Inc
- 10.5.1 Key Facts
- 10.5.2 Business Description
- 10.5.3 Products and Services
- 10.5.4 Financial Overview
- 10.5.5 SWOT Analysis
- 10.5.6 Key Developments
10.6 B Braun SE
- 10.6.1 Key Facts
- 10.6.2 Business Description
- 10.6.3 Products and Services
- 10.6.4 Financial Overview
- 10.6.5 SWOT Analysis
- 10.6.6 Key Developments
10.7 Fresenius Kabi AG
- 10.7.1 Key Facts
- 10.7.2 Business Description
- 10.7.3 Products and Services
- 10.7.4 Financial Overview
- 10.7.5 SWOT Analysis
- 10.7.6 Key Developments
10.8 Vifor Pharma Management AG
- 10.8.1 Key Facts
- 10.8.2 Business Description
- 10.8.3 Products and Services
- 10.8.4 Financial Overview
- 10.8.5 SWOT Analysis
- 10.8.6 Key Developments
10.9 Aculife Healthcare Pvt Ltd
- 10.9.1 Key Facts
- 10.9.2 Business Description
- 10.9.3 Products and Services
- 10.9.4 Financial Overview
- 10.9.5 SWOT Analysis
- 10.9.6 Key Developments

11. Appendix

11.1 About The Insight Partners
11.2 Glossary of Terms

簡介目錄圖表

List Of Tables

Table 1. Parenteral Nutrition Market Segmentation
Table 2. United States: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million) - by Nutrient Type
Table 3. United States: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 4. Canada: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million) - by Nutrient Type
Table 5. Canada: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 6. Mexico: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million) - by Nutrient Type
Table 7. Mexico: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 8. Recent Organic Growth Strategies in the Parenteral Nutrition Market
Table 9. Glossary of Terms, Parenteral Nutrition Market

List Of Figures

Figure 1. Parenteral Nutrition Market Segmentation, By Country
Figure 2. Parenteral Nutrition Market: Key Industry Dynamics
Figure 3. Parenteral Nutrition Market: Impact Analysis of Drivers and Restraints
Figure 4. Parenteral Nutrition Market Revenue (US$ Mn), 2020 - 2030
Figure 5. Parenteral Nutrition Market Share (%) - by Nutrient Type (2022 and 2030)
Figure 6. Single Dose Amino Acid Solution: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
Figure 7. Parenteral Lipid Emulsion: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
Figure 8. Carbohydrates: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
Figure 9. Trace Elements: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
Figure 10. Vitamins and Minerals: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
Figure 11. Parenteral Nutrition Market Share (%) - by End User (2022 and 2030)
Figure 12. Hospitals: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
Figure 13. Clinics: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
Figure 14. Others: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
Figure 15. North America: Parenteral Nutrition Market, by Key Country - Revenue (2022) (US$ Million)
Figure 16. North America: Parenteral Nutrition Market Breakdown, by Key Countries, 2022 and 2030 (%)
Figure 17. United States: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million)
Figure 18. Canada: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million)
Figure 19. Mexico: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million)